Loading
Loading…
Loading…
Ref. No.
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
| # | Company | Offered Item | Status |
|---|---|---|---|
| 1 | Not yet disclosed by govt. Qualified Make: Unbranded--VENOR PHARMA LIMITED
Model: Morphine Sulphate Injection IP | Make: Unbranded--VENOR PHARMA LIMITED
Model: Morphine Sulphate Injection IP | Qualified MSE, Category: General |
Tender Value
Refer Docs
EMD Value
Exempted
Closing Date
11 Mar 2026, 2:00 pmClosed
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
Morphine Injection (Q2) ( ( 3 3 ))
8999321
GEM/2026/B/7250847
Two Packet Bid
Morphine Injection
Delhi; Pali, Rajasthan; New Delhi
Total value wise evaluation
PRODUCT
8 documents required · 8 mandatory
₹31
50%
| Item | Delivery Location | Qty | Delivery |
|---|---|---|---|
| Morphine Injection (Q2) | Vivek 110001,dr.rammanoharlohiahospitalbaba kharaksinghmargnewdelhi | 500 | - |
Exempted
Yes
11 Mar 2026
17 Feb 2026
11 Mar 2026
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_8999321.pdf
GEM_BID
IP_301e10f1-9ed9-44a3-98d21771316601834_AKHILRAI.pdf
OTHER
ATC_82e80228-1851-4332-b08c1771316630143_AKHILRAI.pdf
OTHER
list-of-categories-where-trials-are-allowed_1712126171.pdf
OTHER
gtc.pdf
OTHER
IP_301e10f1-9ed9-44a3-98d21771316601834_AKHILRAI.pdf
GEM_OTHER • 0.26 MB
ATC_82e80228-1851-4332-b08c1771316630143_AKHILRAI.pdf
GEM_OTHER • 0.21 MB
list-of-categories-where-trials-are-allowed_1712126171.pdf
GEM_OTHER • 0.52 MB
gtc.pdf
GEM_OTHER • 0.70 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .